1. Medtech Insight
  3. >>Surgery
  4. >>Robotic Surgery

After Two-Year Delay, J&J Plans To Start Trial Ottava Surgical Robot In 2024

 
• By Reed Miller

J&J originally projected its Ottava soft-tissue robotic surgery system would enter first-in-human trials in 2022 and reach the market by 2023, but the development has been delayed by technical challenges and COVID-19-related disruptions. Now the company plans to start trials of a four-armed version of the device in about a year.

• Source: Shutterstock

After a series of delays, Johnson & Johnson MedTech is almost ready to launch the first-in-human clinical trial of its Ottava soft-tissue robotic surgery system.

On 7 November, the company announced plans to request an investigational device exemption (IDE) from the US Food & Drug Administration to

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Robotic Surgery

More from Surgery